Registered number |
Registered number: | |||||||
Balance Sheet | |||||||
as at |
|||||||
Notes | 2023 | 2022 | |||||
£ | £ | ||||||
Fixed assets | |||||||
Tangible assets | 4 | ||||||
Investments | 5 | ||||||
Current assets | |||||||
Stocks | |||||||
Debtors | 6 | ||||||
Cash at bank and in hand | |||||||
Creditors: amounts falling due within one year | 7 | ( |
( |
||||
Net current liabilities | ( |
( |
|||||
Total assets less current liabilities | ( |
( |
|||||
Creditors: amounts falling due after more than one year | 8 | - | ( |
||||
Provisions for liabilities | - | ( |
|||||
Net liabilities | ( |
( |
|||||
Capital and reserves | |||||||
Called up share capital | |||||||
Profit and loss account | ( |
( |
|||||
Shareholders' funds | ( |
( |
|||||
Dr. Amrut Naik | |||||||
Director | |||||||
Approved by the board on |
|||||||
Notes to the Accounts | ||||||||
for the period from 1 January 2023 to |
||||||||
1 | Accounting policies | |||||||
Basis of preparation | ||||||||
Changes in the accounting reference dates | ||||||||
During the year, the company changed its accounting reference date from 31 December to 6 Novemeber. As a result, the current financial statements cover an 10-month period from 1 January 2023 to 6 November 2023. The comparative figures cover the 12-month period ended 31 December 2022. | ||||||||
Going concern | ||||||||
The company has support from the shareholders for any funding requirements. The directors have confirmed continued support and consider the company retains sufficient working capital to continue trading for the foreseeable future. They continue to believe that the going concern basis of accounting is appropriate in preparing the financial statements. | ||||||||
Turnover | ||||||||
Research and development | ||||||||
Research and development expenditure is written off to the profit and loss account in the year in which it is incurred. | ||||||||
Tangible fixed assets | ||||||||
Freehold buildings | 4% straight line | |||||||
Fixture and fittings | 25% reducing balance | |||||||
Plant and machinery | 25% reducing balance | |||||||
Investments | ||||||||
Stocks | ||||||||
Debtors | ||||||||
Creditors | ||||||||
Taxation | ||||||||
Provisions | ||||||||
Foreign currency translation | ||||||||
Pensions | ||||||||
2 | Audit information | |||||||
Senior statutory auditor: | ||||||||
Firm: | ||||||||
Date of audit report: | ||||||||
3 | Employees | 2023 | 2022 | |||||
Number | Number | |||||||
Average number of persons employed by the company | ||||||||
4 | Tangible fixed assets | |||||||
Land and buildings | Plant and machinery etc | Total | ||||||
£ | £ | £ | ||||||
Cost | ||||||||
At 1 January 2023 | ||||||||
Additions | - | |||||||
At 6 November 2023 | ||||||||
Depreciation | ||||||||
At 1 January 2023 | ||||||||
Charge for the period | ||||||||
At 6 November 2023 | ||||||||
Net book value | ||||||||
At 6 November 2023 | ||||||||
At 31 December 2022 | ||||||||
5 | Investments | |||||||
Investments in | ||||||||
subsidiary | ||||||||
undertakings | ||||||||
£ | ||||||||
Cost | ||||||||
At 1 January 2023 | ||||||||
At 6 November 2023 | ||||||||
There was no movement in fixed assets investments during the period. | ||||||||
6 | Debtors | 2023 | 2022 | |||||
£ | £ | |||||||
Trade debtors | ||||||||
Amounts owed by group undertakings and undertakings in which the company has a participating interest | ||||||||
Other debtors | ||||||||
7 | Creditors: amounts falling due within one year | 2023 | 2022 | |||||
£ | £ | |||||||
Bank loans and overdrafts | - | 9,695 | ||||||
Trade creditors | ||||||||
Taxation and social security costs | ||||||||
Other creditors | ||||||||
8 | Creditors: amounts falling due after one year | 2023 | 2022 | |||||
£ | £ | |||||||
Bank loans | - | |||||||
9 | Events after the reporting date | |||||||
10 | Related party transactions | 2023 | 2021 | |||||
£ | £ | |||||||
Liqmeds Limited | ||||||||
Common director | ||||||||
Turnover includes the work carried out for Liqmeds Limited of: | 1,915,435 | 720,333 | ||||||
Included within other creditor is an amount payable to Liqmeds Limited of: | - | 887,324 | ||||||
Liqmeds Lifecare Limited | ||||||||
Common director | ||||||||
Included within other creditor is an amount payable to Liqmeds Limited of: | 1,098,710 | - | ||||||
Liqmeds Worldwide Limited | ||||||||
Common director | ||||||||
Turnover includes the work carried out for Liqmeds Worldwide Limited of: |
7,490,848 | 2,650,000 | ||||||
During the year the company purchases goods and services from Liqmeds Worldwide Limited of: |
68,989 | - | ||||||
Included within trade debtors is an amount receivable from Liqmeds Worldwide Limited: | 1,800,570 | - | ||||||
Included within other debtors is an amount receivable from Liqmeds Worldwide Limited: | 258,832 | - | ||||||
Included within trade creditors is an amount payable to Liqmeds Worldwide Limited: | - | 833,975 | ||||||
L M Manufacturing India Private Limited - a company incorporated in India |
||||||||
Common director | ||||||||
During the year the company received goods and services from L M Manufacturing India Private Limited of: |
- | 518,282 | ||||||
Included within trade creditors is an amount payable to L M manufacturing India Private Limited of: |
126,500 | - | ||||||
Included within amount receivable from group undertakings is an amount receivable from L M Manufacturing India Private Limited of: | - | 727 | ||||||
UDAJ Limited | ||||||||
Common director | ||||||||
Included within other creditors is an amount payable to UDAJ Limited of: | - | 30,000 | ||||||
Medsolutions (Europe) Limited | ||||||||
Turnover includes the work carried out for Medsolutions (Europe) Limited of: | 300,000 | - | ||||||
Included within trade creditors is an amount payable to Medsolutions (Europe) Limited of: | 69,490 | - | ||||||
Included within other debtor is an amount receivable from Medsolutions (Europe) Limited of: | 121,611 | 6,797 | ||||||
Zydus Pharmaceuticals UK Limited | ||||||||
Common director | ||||||||
Included within other creditors is an amount payable to Zydus Pharmaceuticals UK Limited of: | 15,391,895 | - | ||||||
11 | Controlling party | |||||||
12 | Other information | |||||||
L M MANUFACTURING LIMITED is a private company limited by shares and incorporated in England. Its registered office is: | ||||||||
Sandretto Building | ||||||||
Cavalry Hill Industrial Park | ||||||||
Weedon | ||||||||
Northampton | ||||||||
NN7 4PP |